N2N Technologies Pays Listing Fees, Applies for Trading Suspension Revocation
N2N Technologies Limited has cleared its outstanding annual listing fees with BSE and submitted an application for revocation of trading suspension, marking a significant step toward resuming trading operations. The company also provided transparency regarding promoter Rahul Shah's legal proceedings in Illinois courts, emphasizing these matters are unrelated to company operations, while Harmony Remedies' open offer for 40% stake acquisition remains active.
*this image is generated using AI for illustrative purposes only.
N2N Technologies Limited has taken significant steps toward resuming trading operations by paying overdue annual listing fees to BSE Limited and submitting an application for revocation of trading suspension. The company also provided updates regarding promoter Rahul Shah's legal proceedings in the United States.
Trading Suspension Revocation Update
The company has cleared its outstanding annual listing fees with BSE Limited, addressing the primary reason for the suspension of trading in its equity shares. N2N Technologies has now formally applied for revocation of the trading suspension and indicated it will provide further updates as developments occur.
| Status Update | Details |
|---|---|
| Application Filed | Revocation of trading suspension |
| Fees Status | Annual listing fees paid to BSE |
| Scrip Code | 512279 |
| Next Steps | Awaiting BSE approval for trading resumption |
Promoter Legal Matter Disclosure
N2N Technologies has disclosed that promoter Rahul Shah, a US citizen who has established various IT companies with global operations, is currently defending civil and criminal cases in Illinois state courts. The company emphasized that these legal proceedings are completely unrelated to its business affairs and operations.
Open Offer Context
This development comes as Harmony Remedies India Private Limited continues its open offer to acquire up to 12,91,228 equity shares (40% of expanded voting share capital) at ₹4.30 per share. The tendering period for this offer runs from December 18, 2025, to January 1, 2026, with a total consideration of ₹55.52 lakh.
| Open Offer Details | Value |
|---|---|
| Acquirer | Harmony Remedies India Private Limited |
| Offer Size | 12,91,228 equity shares |
| Offer Price | ₹4.30 per share |
| Total Consideration | ₹55.52 lakh |
| Escrow Amount | ₹56.00 lakh |
Implications for Shareholders
The payment of listing fees and application for trading suspension revocation represents a positive step for N2N Technologies shareholders. If approved by BSE, the resumption of trading would provide liquidity options for investors, particularly those considering the ongoing open offer from Harmony Remedies.
Harmony Remedies has previously indicated plans to diversify N2N Technologies' operations into the pharmaceutical sector while evaluating restructuring opportunities. The potential revival of trading status could facilitate these strategic initiatives and provide better market visibility for the company's transformation plans.
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
